Annual D&A
$1.52 M
+$590.00 K+63.65%
31 December 2023
Summary:
Mersana Therapeutics annual depreciation & amortization is currently $1.52 million, with the most recent change of +$590.00 thousand (+63.65%) on 31 December 2023. During the last 3 years, it has risen by +$507.00 thousand (+50.20%). MRSN annual D&A is now at all-time high.MRSN Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$402.00 K
-$1000.00-0.25%
30 September 2024
Summary:
Mersana Therapeutics quarterly depreciation & amortization is currently $402.00 thousand, with the most recent change of -$1000.00 (-0.25%) on 30 September 2024. Over the past year, it has dropped by -$25.00 thousand (-5.85%). MRSN quarterly D&A is now -10.07% below its all-time high of $447.00 thousand, reached on 31 December 2023.MRSN Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$1.68 M
-$25.00 K-1.47%
30 September 2024
Summary:
Mersana Therapeutics TTM depreciation & amortization is currently $1.68 million, with the most recent change of -$25.00 thousand (-1.47%) on 30 September 2024. Over the past year, it has increased by +$323.00 thousand (+23.89%). MRSN TTM D&A is now -1.47% below its all-time high of $1.70 million, reached on 30 June 2024.MRSN TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MRSN Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +63.6% | -5.8% | +23.9% |
| 3 y3 years | +50.2% | +89.6% | +85.3% |
| 5 y5 years | +20.7% | +29.7% | +27.6% |
MRSN Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +77.4% | -10.1% | +96.1% | -1.5% | +100.8% |
| 5 y | 5 years | at high | +77.4% | -10.1% | +96.1% | -1.5% | +100.8% |
| alltime | all time | at high | +410.8% | -10.1% | +249.6% | -1.5% | +1356.5% |
Mersana Therapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $402.00 K(-0.2%) | $1.68 M(-1.5%) |
| June 2024 | - | $403.00 K(-4.7%) | $1.70 M(+4.9%) |
| Mar 2024 | - | $423.00 K(-5.4%) | $1.62 M(+6.9%) |
| Dec 2023 | $1.52 M(+63.6%) | $447.00 K(+4.7%) | $1.52 M(+12.2%) |
| Sept 2023 | - | $427.00 K(+31.8%) | $1.35 M(+18.8%) |
| June 2023 | - | $324.00 K(+1.6%) | $1.14 M(+9.3%) |
| Mar 2023 | - | $319.00 K(+13.1%) | $1.04 M(+12.3%) |
| Dec 2022 | $927.00 K(+8.4%) | $282.00 K(+32.4%) | $927.00 K(+8.3%) |
| Sept 2022 | - | $213.00 K(-6.2%) | $856.00 K(+0.1%) |
| June 2022 | - | $227.00 K(+10.7%) | $855.00 K(+2.5%) |
| Mar 2022 | - | $205.00 K(-2.8%) | $834.00 K(-2.5%) |
| Dec 2021 | $855.00 K(-15.3%) | $211.00 K(-0.5%) | $855.00 K(-5.4%) |
| Sept 2021 | - | $212.00 K(+2.9%) | $904.00 K(-4.6%) |
| June 2021 | - | $206.00 K(-8.8%) | $948.00 K(-4.0%) |
| Mar 2021 | - | $226.00 K(-13.1%) | $988.00 K(-2.2%) |
| Dec 2020 | $1.01 M | $260.00 K(+1.6%) | $1.01 M(-2.1%) |
| Sept 2020 | - | $256.00 K(+4.1%) | $1.03 M(-5.0%) |
| June 2020 | - | $246.00 K(-0.8%) | $1.09 M(-6.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | $248.00 K(-12.1%) | $1.16 M(-7.1%) |
| Dec 2019 | $1.25 M(-1.0%) | $282.00 K(-9.0%) | $1.25 M(-5.2%) |
| Sept 2019 | - | $310.00 K(-1.9%) | $1.31 M(-2.4%) |
| June 2019 | - | $316.00 K(-6.2%) | $1.34 M(+0.7%) |
| Mar 2019 | - | $337.00 K(-3.7%) | $1.34 M(+6.3%) |
| Dec 2018 | $1.26 M(+35.5%) | $350.00 K(+2.3%) | $1.26 M(+8.2%) |
| Sept 2018 | - | $342.00 K(+11.4%) | $1.16 M(+10.1%) |
| June 2018 | - | $307.00 K(+19.0%) | $1.05 M(+8.0%) |
| Mar 2018 | - | $258.00 K(+1.2%) | $977.00 K(+5.3%) |
| Dec 2017 | $928.00 K(+41.7%) | $255.00 K(+8.5%) | $928.00 K(+5.6%) |
| Sept 2017 | - | $235.00 K(+2.6%) | $879.00 K(+6.2%) |
| June 2017 | - | $229.00 K(+9.6%) | $828.00 K(+10.5%) |
| Mar 2017 | - | $209.00 K(+1.5%) | $749.00 K(+14.4%) |
| Dec 2016 | $655.00 K(+120.5%) | $206.00 K(+12.0%) | $655.00 K(+45.9%) |
| Sept 2016 | - | $184.00 K(+22.7%) | $449.00 K(+69.4%) |
| June 2016 | - | $150.00 K(+30.4%) | $265.00 K(+130.4%) |
| Mar 2016 | - | $115.00 K | $115.00 K |
| Dec 2015 | $297.00 K | - | - |
FAQ
- What is Mersana Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Mersana Therapeutics?
- What is Mersana Therapeutics annual D&A year-on-year change?
- What is Mersana Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Mersana Therapeutics?
- What is Mersana Therapeutics quarterly D&A year-on-year change?
- What is Mersana Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for Mersana Therapeutics?
- What is Mersana Therapeutics TTM D&A year-on-year change?
What is Mersana Therapeutics annual depreciation & amortization?
The current annual D&A of MRSN is $1.52 M
What is the all time high annual D&A for Mersana Therapeutics?
Mersana Therapeutics all-time high annual depreciation & amortization is $1.52 M
What is Mersana Therapeutics annual D&A year-on-year change?
Over the past year, MRSN annual depreciation & amortization has changed by +$590.00 K (+63.65%)
What is Mersana Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of MRSN is $402.00 K
What is the all time high quarterly D&A for Mersana Therapeutics?
Mersana Therapeutics all-time high quarterly depreciation & amortization is $447.00 K
What is Mersana Therapeutics quarterly D&A year-on-year change?
Over the past year, MRSN quarterly depreciation & amortization has changed by -$25.00 K (-5.85%)
What is Mersana Therapeutics TTM depreciation & amortization?
The current TTM D&A of MRSN is $1.68 M
What is the all time high TTM D&A for Mersana Therapeutics?
Mersana Therapeutics all-time high TTM depreciation & amortization is $1.70 M
What is Mersana Therapeutics TTM D&A year-on-year change?
Over the past year, MRSN TTM depreciation & amortization has changed by +$323.00 K (+23.89%)